Zummo Jacqueline
Protara Therapeutics, Inc. · Chief R&D Officer
Zummo Jacqueline is listed in filings as Chief R&D Officer at Protara Therapeutics, Inc.. This profile follows SEC Form 4 activity through Apr 9, 2026, including sale activity. Recent filings connect the profile to Protara Therapeutics, Inc. (TARA). The current snapshot covers public activity from Jan 7, 2025 to Apr 9, 2026. Reported amounts are shown as $6.1K to $24.8K. The page organizes purchases, sales, issuer links, reported share activity, and filing evidence for review as public disclosure data.
History Trades
| Company | Value | Action | Price | Last Price |
|---|---|---|---|---|
| $119k22.6k shares | SellApr 1, 2026 | $5.26 | $4.76 | |
| $96k21.2k shares | SellMar 26, 2025 | $4.53 | $4.76 |